Leaders of Northwestern Medicine have made a transformational commitment of more than $1 billion toward creating a leading medical research enterprise on the Chicago campus. The investment includes construction of additional research space, which will attract more top scientists to Northwestern and create more opportunities to discover breakthroughs in areas such as neuroscience, heart disease, diabetes, and cancer in children and adults.

An early and sharp increase in patient cases has resulted in one of the most severe starts to a flu season in several years. Learn what flu experts are saying about this year's outbreak.  Read more >

Events celebrating the life and legacy of Martin Luther King Jr. will continue through Thursday at the medical school. Upcoming programs include a reception and awards ceremony this evening and a panel discussion tomorrow.  Read more >

Margot Hamel-Christensen shares her emotional story of an unexpected diagnosis of advanced liver disease and the transplant that saved her.   Read more >

Through a new CCARES program, more than 25 medical and physician assistant students from across Chicago completed training last week on how to teach hands-only CPR and use an automated external defibrillator. The ultimate goal of the program is to build community awareness of these lifesaving skills.

Konrad Hochedlinger, PhD, assistant professor in the Department for Stem Cell and Regenerative Biology at Harvard University and a Howard Hughes investigator, will present "Mechanisms of Cellular Reprogramming to Pluripotency" as part of the Lectures in Life Sciences series at 4 p.m. on Tuesday, January 22 in Hughes Auditorium at the Robert H. Lurie Medical Research Center of Northwestern University. Hochedlinger's research attempts to identify and characterize the biological factors that control the choice of embryonic stem cells to either self-renew or specialize under normal conditions and in disease. He completed his bachelor's degree in biology at the University of Vienna in Austria. He earned his master's degree in genetics and his PhD in mammalian development at the Research Institute of Molecular Pathology in Austria.